You are in: eMedicine Specialties > Emergency Medicine > EPIDEMIOLOGY Screening and Diagnostic TestsArticle Last Updated: Nov 26, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Jyoti Elavunkal, MD, Staff Physician, Department of Emergency Medicine, State University of New York Downstate Medical Center, Brooklyn, Kings County Hospital Center Jyoti Elavunkal is a member of the following medical societies: American Medical Association, American Medical Student Association/Foundation, and Society for Academic Emergency Medicine Coauthor(s): Richard Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center Editors: Jerome FX Naradzay, MD, FACEP, Medical Director, Consulting Staff, Department of Emergency Medicine, Maria Parham Hospital; Medical Examiner, Vance County, North Carolina; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Jon Mark Hirshon, MD, MPH, Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System Author and Editor Disclosure Synonyms and related keywords: screening tests, diagnostic tests, disease probability, negative predictive value, positive predictive value, sensitivity, specificity, assessment, pretest probability, posttest probability, pre-test probability, post-test probability INTRODUCTIONDiagnostic tests help physicians revise disease probability for their patients. All tests should be ordered by the physician to answer a specific question. The 5 main reasons for a diagnostic test are as follows:
The criterion (reference) standard test definitively decides either presence or absence of a disease. Examples of criterion standard tests include pathological specimens for malignancies and pulmonary angiography for pulmonary embolism. However, criterion standard tests routinely come with drawbacks; they are usually expensive, less widely available, more invasive, and riskier. These issues usually compel most physicians to choose other diagnostic tests as surrogates for their criterion standard test. For example, venography, the criterion standard for vein thrombosis, is an invasive procedure with significant complications including renal failure, allergic reaction, and clot formation. These risks make venography less desirable than the alternative diagnostic test—venous duplex ultrasonography. The price most diagnostic tests pay for their ease of use compared with their criterion standard is a decrease in accuracy. How to account for this trade-off between diagnostic accuracy and patient acceptability is the subject of this article. PRETEST AND POSTTEST PROBABILITYEvery clinical encounter begins with an initial clinical impression, a subjective pretest probability of disease. The ultimate goal of all diagnostic testing is to refine this pretest probability to the point where the physician can confidently make a treat or no-treat decision. Each diagnostic test whether it is a symptom, sign, laboratory, or radiological examination results in a change in the physician’s probability of disease, the posttest probability. The degree to which a diagnostic test increases or decreases the probability of disease from pretest to posttest represents the clinical utility of the test as measured by its operating characteristics. DEFINITIONS AND CALCULATIONSClinical studies of diagnostic tests measure the accuracy of the test against its criterion standard.
Table 2. Definition of Terms
SENSITIVITY AND SPECIFICITYDifferent diagnostic tests for the same disease often trade sensitivity for specificity or vice versa. In general, the more sensitive a test is for a disease, the higher its false-positive rate, lowering its specificity. A test with a higher specificity will usually sacrifice sensitivity by increasing its false-negative rate. This makes a highly sensitive test ideal for a screening examination. While, highly specific tests are best in a confirmatory role. Sensitivity and specificity are calculated vertically in a 2 X 2 table. Sensitivity is measured in patients definitively diagnosed with the disease, whereas specificity is only a function of those free of disease. Sensitivity contains no information about false-positive results, and specificity does not account for false-negative results. This limits the applicability of sensitivity and specificity in predicting disease when the physician is uncertain about the diagnosis. For example, a positive test result with 90% sensitivity does not predict a 90% probability of disease in a patient. The mnemonics SnOut and SpIn provide some guidelines on how to interpret sensitivity and specificity for an individual patient. SnOut helps physicians to remember that a highly Sensitive test with a negative result is good at ruling-out the disease. SpIn reminds physicians that a highly Specific test with a positive result is good at ruling-in the disease. PREDICTIVE VALUESTo estimate the posttest probability for an individual patient another statistic is needed. Predictive values are horizontally calculated operating characteristics, which incorporate both false-positive and false-negative results into disease probability. The positive predictive value (PPV) is the probability of a patient actually having the disease if the test result is positive. The probability of the patient being free of the disease after a negative test result is given by the negative predictive value (NPV). For example, chest CT angiography with venous runoff (CTA VN) has a sensitivity of 90% and specificity of 95%. In a patient with a high probability (78.4%) of a pulmonary embolism according to the Wells’ criteria, the CTA VN would produce a PPV of 99% and NPV of 72%. The same test given to a patient with a much lower pretest probability of pulmonary embolism (3.4%) would result in a PPV of 39% and NPV of 99%. BAYES' THEOREM AND LIKELIHOOD RATIOSBayes’ Theorem Adapting a theory of conditional probability from the 18th century statistician Thomas Bayes solves the problem of calculating posttest disease probability. This theory allows pretest probability to be separated from a term that describes the strength of the diagnostic test—likelihood ratio.
Likelihood Ratio Likelihood ratios are proportions of probabilities. A likelihood ratio for a positive test result (LR+) is the ratio of the true positive rate (sensitivity) divided by the false-positive rate (1 - specificity). LR+ then can be thought of how much more likely the patient is to actually have the disease after a positive test result. Dividing the false-negative rate (1 - sensitivity) by the true negative rate (specificity) gives the likelihood ratio for a negative test result and provides the strength of a negative test result in convincing the physician the patient is free of disease. Since likelihood ratios are calculated from sensitivity and specificity, LRs are stable operating test characteristics, unaffected by prevalence of disease. A LR of 1.0 is a useless test because this result fails to change the opinion of probability of disease from pretest to posttest. LR+ are always greater than 1.0; the larger the number, the more likely is the patient to have the disease after a positive test result. LR- are always less than 1.0, with the smaller numbers signifying a lower risk for disease than pretest estimates. Table 3. Strength of the Test by Likelihood Ratio
USING BAYES' THEOREMThis form of Bayes’ theorem using likelihood ratios requires the conversion of pretest probability to odds multiplied by the appropriate LR and then reconverted to the posttest odds, back into posttest probability. Example: What is the probability of a pulmonary embolism in a patient after a positive CTA VN (sensitivity 90%, specificity 95%) if the patient has a pretest probability of 28%?
This method requires multiple steps and is inconvenient for bedside use. In 1975, Fagan published a nomogram for the graphical calculation of Bayes’ theorem. This nomogram (see Media file 1) only requires drawing a straight line from the patient’s pretest probability through the appropriate LR connecting to the posttest probability. ACKNOWLEDGMENTSThe authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Theodore Gaeta, DO, to the development and writing of this article. MULTIMEDIA
REFERENCES
Screening and Diagnostic Tests excerpt Article Last Updated: Nov 26, 2007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||